Skip to main content
. 2021 Jun 27;22(13):6904. doi: 10.3390/ijms22136904

Table 1.

Significant RAGE ligands.

RAGE Ligands RAGE Binding Domain Clinical Significance Ref.
Endogenous RAGE Ligands
AGEs V Diabetes, chronic inflammation and cancer [28]
S100/calgranulins V or VC1 or V2 Inflammatory response and cancer differentiation and progression [64]
HMGB1 VC1C2 Cancer development and metastasis and drug resistance [65]
β-sheet fibrils V Neuronal disease: Alzheimer’s disease [66]
Mac1 RAGE-mediated leukocyte recruitment [45]
Quinolinic acids VC1 Neuronal disease: Huntington’s disease [67]
LPA V Cell proliferation and migration in C6 glioma and smooth muscle cells [68]
PS Rac1 activation in alveolar macrophages [69]
C1q Recruitment of leukocytes and phagocytosis [70]
mDia1 cytoplasmic Initiation and activation of RAGE-mediated signaling [13]
Exogenous RAGE Ligands
RNA or DNA VC1 RAGE-mediated augmentation of inflammation [8]
RSV F protein VC1 Promote the survival of RSV-infected cells [11]
Longistatin V Longistatin acts as an antagonist to RAGE and suppresses inflammation [12]

AGEs: Advanced glycation end-products; HMGB1: High mobility group box-1 protein; LPA: Lysophosphatidic acid; PS: Phosphatidylserine; mDia1: Mammalian diaphanous 1; RSV: Respiratory syncytial virus.